قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The & # 39; prescription bias & # 39; can be seen by diabetics who miss over statins, studies suggest

The & # 39; prescription bias & # 39; can be seen by diabetics who miss over statins, studies suggest



Women with Type 2 diabetes are more likely than males to prescribe statins to prevent heart attacks and strokes, suggesting new research.

The condition, which occurs when the body does not make insulin properly, increases the risk of cardiovascular Diseases in both sexes.

However, a study, published in the Circulation journal, indicates that there may be a "prescription bias" in treatment.

The study, funded by Diabetes UK's charity, has also found that men and women in today's condition are experiencing a similar increase in their risk of cardiovascular disease.

Previously, a higher proportionate increase was seen among women, authors Researchers from the University of Manchester told the data on 80,000 newly diagnosed with Type 2 diabetes in England between 2006 and 201

3.

Among these groups, 11.6% of women and 12.8% of men continued to develop cardiovascular

This was compared to 7.4% of women and 8.1% of non-diabetic men.

Meanwhile, women with Type 2 diabetes are 26% more likely to be prescribed ACE inhibitors and 16% receive statins than people with conditions.

They also found that women who show some symptoms of heart disease are 37% more likely to receive ACE inhibitors and 41% are more likely to receive statins than men. 02] Dr. Elizabeth Robertson, director of research at Diabetes UK: "New results suggest that the outlook for women with Type 2 diabetes is better than previously thought, thanks to improved care." make sure everyone with Type 2 diabetes is getting the best treatment and care, to reduce their risk of cardiovascular complications that threaten life such as heart attack or stroke as long as possible. "

Researchers believe that gender bias in prescriptions may be due to the differences in the symptoms of heart disease between men and women, or the attitudes of workers and health patients.

Dr. Martin Rutter, senior researcher at the University of Manchester said: "Further research is now needed to understand the reasons for the prescribing differences between men and women and to find ways to close the space.

"Primary care study is especially important, because it is where most people with Type 2 are being treated."

– Press the Association


Source link